Portfolio company
AKYA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides spatial phenotyping solutions to researchers and clinicians for visualizing and quantifying protein and RNA expression in tissue sections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
2NA FISH
The company develops spatial transcriptomics technology using nanotechnology and AI to provide precision diagnostics for healthcare providers and researchers.
KANVAS
This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.
Cubase Bio
This company develops optics-free DNA microscopy kits for three-dimensional spatial transcriptomics to support drug discovery and disease research for pharmaceutical and academic organisations.
Rebus Biosystems, Inc.
This life science technology company develops automated spatial omics platforms for researchers and pharmaceutical groups to analyse gene expression within tissue samples.
Pixelgen Technologies
Pixelgen Technologies develops spatial proteomics kits and software for researchers in immunology, oncology and drug development to map cell surface protein architecture.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
RareCyte
RareCyte develops multiplexed imaging instruments and consumables for spatial biology and liquid biopsy, serving pharmaceutical companies and academic researchers in life sciences.
PhenoTA
This company develops automated blood testing technology using Raman spectroscopy and artificial intelligence for next-generation hematology laboratories.
